臨床試驗進度
| Pipeline | Indication | Region | CAR engineering | Pre-clinical | Phase I | Phase II/ III |
|---|---|---|---|---|---|---|
| UBP-3001 (UWC19) |
B cell malignancies |
China | First in human | |||
| UBP-3002 (UWC19) |
Non-Hodgkin lymphoma |
Taiwan | ||||
| UBP-3003 (UWC19) |
B cell malignancies |
Malaysia | ||||
| UBP-3004 (UWC19) |
Lymphoblastic leukemia |
Taiwan | ||||
| UBP-3005 (UWC19) |
Non-Hodgkin lymphoma |
China | ||||
| UBP-Her2-CART (UWHer2T) |
Solid tumour | Taiwan | ||||
| UBP-alloNK-19 (UWC19-aNK) |
B cell malignancies |
Taiwan | ||||
| UBP-alloNK-Her2 | Solid tumour | Taiwan |